DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 05 · Volume 37 · September 2004 DOI: 10.1055/s-002-3589

Original Paper

Original Paper

  • 193
    E , Kuenzel H.; H , Murck; K , Held; M , Ziegenbein; A , Steiger:

    Reboxetine Induces Similar Sleep-EEG Changes Like SSRI’s in Patients with Depression

  • 196
  • 200
  • 206
    Bertani, A.; Perna, G.; Migliarese, G.; Di Pasquale, D.; Cucchi, M.; Caldirola, D.; Bellodi, L.:

    Comparison of the Treatment with Paroxetine and Reboxetine in Panic Disorder: A Randomized, Single-Blind Study

  • 211
    Klumpers, U. M. H.; Boom, K.; Janssen, F. M. G.; Tulen, J. H. M.; Loonen, A. J. M.:

    Cardiovascular Risk Factors in Outpatients with Bipolar Disorder

  • 217
  • 221
  • 228
  • Letter

  • 236
  • 238
    Lieb, K.; Walden, J.; Grunze, H.; Fiebich, B. L.; Berger, M.; Normann, C.:

    Serum Levels of Substance P and Response to Antidepressant Pharmacotherapy

  • 239
  • 240
  • 242
    Keszthelyi, Z.; Past, T.; Lukáts, B.; Koltai, K.; Karádi, Z.:

    The Central Effect of Chromium on Glucose Metabolism